Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
X4 Pharmaceuticals revenue
X4 Pharmaceuticals's revenue is $2.6 million.
What is X4 Pharmaceuticals's revenue?
- X4 Pharmaceuticals peak revenue was $3.0M in 2020.
- X4 Pharmaceuticals annual revenue for 2024 was 2.6M, -14.77% growth from 2020.
- X4 Pharmaceuticals's revenue growth from 2020 to 2024 is -14.77%.
- X4 Pharmaceuticals has 50 employees, and the revenue per employee ratio is $51,140.
- X4 Pharmaceuticals's peak quarterly revenue was $3.0M in 2020(q1).
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
X4 Pharmaceuticals financial information
| CEO | Paula Ragan |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 50 |
| Date Founded | 2014 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 3 |
| Revenue | $2.6M |
| Net Income | -$93,867,000 |
| Gross Proft | $1.8M (2024) |
| Tax Rate | -0.0% |
| Total Assets | $155,586,000 |
| Ticker | XFOR |
X4 Pharmaceuticals jobs you might like
X4 Pharmaceuticals financing
X4 Pharmaceuticals received early financing of $37.5M on 2015-12-15.
| Series | Round size | Date |
|---|---|---|
| Series A | $37.5M | 12/2015 |
| Series B | $27M | 11/2017 |
| Post Ipo Equity | $55M | 03/2021 |
X4 Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Cormorant Asset Management | Series A |
| Cormorant Asset Management | Series B |
| Altium Capital | Post Ipo Equity |
| Ikarian Capital LLC | Post Ipo Equity |
| Abingworth | Post Ipo Equity |
| Bain Capital Life Sciences | Post Ipo Equity |
| Monashee Investment Management LLC | Post Ipo Equity |
| OrbiMed Advisors | Post Ipo Equity |
| LINCOLN PARK CAPITAL | Post Ipo Equity |
| Sio Capital Management LLC | Post Ipo Equity |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Post Ipo Equity |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of X4 Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about X4 Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at X4 Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by X4 Pharmaceuticals. The data presented on this page does not represent the view of X4 Pharmaceuticals and its employees or that of Zippia.
X4 Pharmaceuticals may also be known as or be related to X4 PHARMACEUTICALS, INC, X4 Pharmaceuticals and X4 Pharmaceuticals, Inc.